title: Gabapentin-Induced Bullous Pemphigoid.
abstract: Bullous pemphigoid is an autoimmune blistering dermatosis with separation of the epidermis from the dermis. This disease process is common among elderly patients and manifests with subepidermal vesicles and tense bullae. Patients with bullous pemphigoid are more likely to have also received a previous diagnosis of a neurologic disorder. Gabapentin is an antiepileptic that is used to manage neuropathic pain. The authors describe, to their knowledge, the first report of gabapentin-induced bullous pemphigoid in an elderly man with no history of rashes or reactions to other medications.
authors.forename: Avram
authors.initials: A
authors.lastname: Flamm
authors.forename: Sarina
authors.initials: S
authors.lastname: Sachdev
authors.forename: Francois
authors.initials: F
authors.lastname: Dufresne
mesh_terms: D000369:Aged, 80 and over; D000588:Amines / Q000009:adverse effects* / Q000627:therapeutic use; D001707:Biopsy, Needle; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D005500:Follow-Up Studies; D000077206:Gabapentin; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D010391:Pemphigoid, Bullous / Q000139:chemically induced* / Q000473:pathology*; D035583:Rare Diseases; D018570:Risk Assessment; D012640:Seizures / Q000175:diagnosis / Q000188:drug therapy*; D012720:Severity of Illness Index; D028761:Withholding Treatment; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin